Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

A Center for Stem Cell Disease Modeling and Therapeutics

  • Post author:
  • Post published:June 18, 2026
  • Post category:

The goal of this project is to support the discovery and evaluation of novel therapeutics using stem cell-based models and drug and CRISPR screening. The facility will provide California researchers…

Continue ReadingA Center for Stem Cell Disease Modeling and Therapeutics

Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Research Objective We propose a platform to generate transplantable thymus organoids derived from human pluripotent stem cells designed to treat severe immunodeficiencies in children affected by 22q11 DS Impact Our…

Continue ReadingRegenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome

GENE EDITING FOR FOXP3 IN HUMAN HSC

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Research Objective CRISPR/Cas9 mediated FOXP3 gene editing in patient-derived hematopoietic stem cells as a cure for IPEX syndrome Impact FOXP3 mutation in IPEX syndrome leads to immune system dysregulation. Allogeneic…

Continue ReadingGENE EDITING FOR FOXP3 IN HUMAN HSC

A novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Continue ReadingA novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies

Noncoding RNA drug TY1 as a therapeutic candidate for scleroderma and systemic sclerosis

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Translational Candidate Modified synthetic noncoding RNA molecule Area of Impact Systemic Sclerosis Mechanism of Action The mechanism of action of TY1 is alleviating cell stress and damage through enhancing genes…

Continue ReadingNoncoding RNA drug TY1 as a therapeutic candidate for scleroderma and systemic sclerosis

Ex Vivo Gene Editing of Human Hematopoietic Stem Cells for the Treatment of X-Linked Hyper-IgM Syndrome

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Translational Candidate Human hematopoietic stem cells that have been gene-corrected at the CD40L gene to treat patients with X-Linked Hyper-IgM Syndrome Area of Impact These studies will bring stem cell…

Continue ReadingEx Vivo Gene Editing of Human Hematopoietic Stem Cells for the Treatment of X-Linked Hyper-IgM Syndrome

62nd Midwinter Conference of Immunologists

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Continue Reading62nd Midwinter Conference of Immunologists

Cellular Immune Tolerance Symposium

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Continue ReadingCellular Immune Tolerance Symposium

Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Continue ReadingPrimary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop

TRX103 for prevention of GvHD in patients receiving HLA mismatched HSCT for the treatment of hematologic malignancies

  • Post author:
  • Post published:June 18, 2026
  • Post category:

Continue ReadingTRX103 for prevention of GvHD in patients receiving HLA mismatched HSCT for the treatment of hematologic malignancies
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us